CD44+ Circulating Tumor Endothelial Cells Indicate Poor Prognosis in Pancreatic Ductal Adenocarcinoma After Radical Surgery: A Pilot Study

References

• Siegel RL , Miller KD , Jemal A . Cancer statistics, 2020. CA Cancer J Clin . 2020;70:7–30. doi:10.3322/caac.21590 31912902
   PubMed Web of Science ®Google Scholar
• Wong MCS , Jiang JY , Liang M , Fang Y , Yeung MS , Sung JJY . Global temporal patterns of pancreatic cancer and association with socioeconomic development. Sci Rep . 2017;7(1):3165. doi:10.1038/s41598-017-02997-2 28600530
   PubMed Web of Science ®Google Scholar
• Noone AM , Krapcho M , Miller D , et al.. SEER cancer statistics review, 1975–2015, based on November 2017 SEER data submission, posted to the SEER web site. Bethesda, MD: National Cancer Institute; 2018 cited Apr.
   Google Scholar
• Lin PP . Aneuploid CTC and CEC. Diagnostics (Basel) . 2018;8(2):26. doi:10.3390/diagnostics8020026
   PubMedGoogle Scholar
• Lin PP , Gires O , Wang DD , Li L , Wang H . Comprehensive in situ co-detection of aneuploid circulating endothelial and tumor cells. Sci Rep . 2017;7(1):9789. doi:10.1038/s41598-017-10763-7 28852197
   PubMed Web of Science ®Google Scholar
• Akino T , Hida K , Hida Y , et al. Cytogenetic abnormalities of tumor-associated endothelial cells in human malignant tumors. Am J Pathol . 2009;175(6):2657–2667. doi:10.2353/ajpath.2009.090202 19875502
   PubMed Web of Science ®Google Scholar
• Hida K , Klagsbrun M . A new perspective on tumor endothelial cells: unexpected chromosome and centrosome abnormalities. Cancer Res . 2005;65(7):2507–2510. doi:10.1158/0008-5472.CAN-05-0002 15805239
   PubMed Web of Science ®Google Scholar
• Dudley AC . Tumor endothelial cells. Cold Spring Harb Perspect Med . 2012;2(3):a006536. doi:10.1101/cshperspect.a006536 22393533
   PubMed Web of Science ®Google Scholar
• Hida K , Maishi N , Annan DA , Hida Y . Contribution of tumor endothelial cells in cancer progression. Int J Mol Sci . 2018;19(5):1272. doi:10.3390/ijms19051272
   PubMed Web of Science ®Google Scholar
• Zhao Y , Li J , Li D , et al. Tumor biology and multidisciplinary strategies of oligometastasis in gastrointestinal cancers. Semin Cancer Biol . 2020;60:334–343. doi:10.1016/j.semcancer.2019.08.026 31445220
   PubMed Web of Science ®Google Scholar
• Bertolini F , Shaked Y , Mancuso P , Kerbel RS . The multifaceted circulating endothelial cell in cancer: towards marker and target identification. Nat Rev Cancer . 2006;6(11):835–845. doi:10.1038/nrc1971 17036040
   PubMed Web of Science ®Google Scholar
• Cima I , Kong SL , Sengupta D , et al. Tumor-derived circulating endothelial cell clusters in colorectal cancer. Sci Transl Med . 2016;8(345):345ra89. doi:10.1126/scitranslmed.aad7369
   PubMed Web of Science ®Google Scholar
• Bidard FC , Mathiot C , Degeorges A , et al. Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy. Ann Oncol . 2010;21(9):1765–1771. doi:10.1093/annonc/mdq052 20233745
   PubMed Web of Science ®Google Scholar
• Wang J , Xiao J , Wei X , et al. Circulating endothelial cells and tumor blood volume as predictors in lung cancer. Cancer Sci . 2013;104(4):445–452. doi:10.1111/cas.12097 23298271
   PubMed Web of Science ®Google Scholar
• Lei Y , Sun N , Zhang G , et al. Combined detection of aneuploid circulating tumor-derived endothelial cells and circulating tumor cells may improve diagnosis of early stage non-small-cell lung cancer. Clin Transl Med . 2020;10(3):e128. doi:10.1002/ctm2.128 32659050
   PubMed Web of Science ®Google Scholar
• Grover PK , Cummins AG , Price TJ , et al. Circulating tumor cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer research. Ann Oncol . 2014;25:1506–1516. doi:10.1093/annonc/mdu018 24651410
   PubMed Web of Science ®Google Scholar
• Aktas B , Tewes M , Fehm T , et al. Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients. Breast Cancer Res . 2009;11(4):R46. doi:10.1186/bcr2333 19589136
   PubMed Web of Science ®Google Scholar
• Fan CW , Chen T , Shang YN , et al. Cancer-initiating cells derived from human rectal adenocarcinoma tissues carry mesenchymal phenotypes and resist drug therapies. Cell Death Dis . 2013;4(10):e828. doi:10.1038/cddis.2013.337 24091671
   PubMed Web of Science ®Google Scholar
• Li M , Zhang B , Zhang Z , et al. Stem cell-like circulating tumor cells indicate poor prognosis in gastric cancer. Biomed Res Int . 2014;2014:981261.24963492
   PubMed Web of Science ®Google Scholar
• Poruk KE , Blackford AL , Weiss MJ , et al. Circulating tumor cells expressing markers of tumor-initiating cells predict poor survival and cancer recurrence in patients with pancreatic ductal adenocarcinoma. Clin Cancer Res . 2017;23(11):2681–2690. doi:10.1158/1078-0432.CCR-16-1467 27789528
   PubMed Web of Science ®Google Scholar
• Yu M , Bardia A , Wittner BS , et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science . 2013;339(6119):580–584. doi:10.1126/science.1228522 23372014
   PubMed Web of Science ®Google Scholar
• Huber MA , Kraut N , Beug H . Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol . 2005;17(5):548–558. doi:10.1016/j.ceb.2005.08.001 16098727
   PubMed Web of Science ®Google Scholar
• Poruk KE , Valero V 3rd , Saunders T , et al. Circulating tumor cell phenotype predicts recurrence and survival in pancreatic adenocarcinoma. Ann Surg . 2016;264(6):1073–1081. doi:10.1097/SLA.0000000000001600 26756760
   PubMed Web of Science ®Google Scholar
• Wu G , Zhu R , Li Y , Zhao Y , Dai M . Prognostic significance of circulating tumor microemboli in patients with pancreatic ductal adenocarcinoma. Oncol Lett . 2018;15(5):7376–7382. doi:10.3892/ol.2018.8264 29725451
   PubMed Web of Science ®Google Scholar
• Lin P , Fischer T , Weiss T , Farquhar MG . Calnuc, an EF-hand Ca(2+) binding protein, specifically interacts with the C-terminal alpha5-helix of G(alpha)i3. Proc Natl Acad Sci U S A . 2000;97(2):674–679. doi:10.1073/pnas.97.2.674 10639138
   PubMed Web of Science ®Google Scholar
• Camp RL , Dolled-Filhart M , Rimm DL . X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res . 2004;10(21):7252–7259. doi:10.1158/1078-0432.CCR-04-0713 15534099
   PubMed Web of Science ®Google Scholar
• Barhli A , Cros J , Bartholin L , Neuzillet C . Prognostic stratification of resected pancreatic ductal adenocarcinoma: past, present, and future. Dig Liver Dis . 2018;50(10):979–990. doi:10.1016/j.dld.2018.08.009 30205952
   PubMedGoogle Scholar
• Zhang L , Zhang X , Liu Y , et al. PD-L1+ aneuploid circulating tumor endothelial cells (CTECs) exhibit resistance to the checkpoint blockade immunotherapy in advanced NSCLC patients. Cancer Lett . 2020;469:355–366. doi:10.1016/j.canlet.2019.10.041 31678168
   PubMed Web of Science ®Google Scholar
• Ma G , Jiang Y , Liang M , et al. Dynamic monitoring of CD45-/CD31+/DAPI+ circulating endothelial cells aneuploid for chromosome 8 during neoadjuvant chemotherapy in locally advanced breast cancer. Ther Adv Med Oncol . 2020;12:1758835920918470. doi:10.1177/1758835920918470 32489429
   PubMed Web of Science ®Google Scholar
• Piera-Velazquez S , Mendoza FA , Jimenez SA . Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of human fibrotic diseases. J Clin Med . 2016;5(4):45. doi:10.3390/jcm5040045
   PubMed Web of Science ®Google Scholar
• Cao Z , Livas T , Kyprianou N . Anoikis and EMT: lethal “Liaisons” during cancer progression. Crit Rev Oncog . 2016;21(3–4):155–168. doi:10.1615/CritRevOncog.2016016955 27915969
   PubMedGoogle Scholar
• Calleri A , Bono A , Bagnardi V , et al. Predictive potential of angiogenic growth factors and circulating endothelial cells in breast cancer patients receiving metronomic chemotherapy plus bevacizumab. Clin Cancer Res . 2009;15(24):7652–7657. doi:10.1158/1078-0432.CCR-09-1493 19996223
   PubMed Web of Science ®Google Scholar
• Kondo S , Ueno H , Hashimoto J , et al. Circulating endothelial cells and other angiogenesis factors in pancreatic carcinoma patients receiving gemcitabine chemotherapy. BMC Cancer . 2012;12:268. doi:10.1186/1471-2407-12-268 22731825
   PubMed Web of Science ®Google Scholar
• Kindler HL , Niedzwiecki D , Hollis D , et al. Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303). J Clin Oncol . 2010;28(22):3617–3622. doi:10.1200/JCO.2010.28.1386 20606091
   PubMed Web of Science ®Google Scholar
• Kindler HL , Ioka T , Richel DJ , et al. Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised Phase 3 study. Lancet Oncol . 2011;12(3):256–262. doi:10.1016/S1470-2045(11)70004-3 21306953
   PubMed Web of Science ®Google Scholar
• Crawford Y , Ferrara N . Tumor and stromal pathways mediating refractoriness/resistance to anti-angiogenic therapies. Trends Pharmacol Sci . 2009;30(12):624–630. doi:10.1016/j.tips.2009.09.004 19836845
   PubMed Web of Science ®Google Scholar
• Allen E , Miéville P , Warren CM , et al. Metabolic symbiosis enables adaptive resistance to anti-angiogenic therapy that is dependent on mTOR signaling. Cell Rep . 2016;15(6):1144–1160. doi:10.1016/j.celrep.2016.04.029 27134166
   PubMed Web of Science ®Google Scholar
• Huijbers EJ , van Beijnum JR , Thijssen VL , Sabrkhany S , Nowak-Sliwinska P , Griffioen AW . Role of the tumor stroma in resistance to anti-angiogenic therapy. Drug Resist Updat . 2016;25:26–37. doi:10.1016/j.drup.2016.02.002 27155374
   PubMed Web of Science ®Google Scholar
• Molejon MI , Tellechea JI , Moutardier V , et al. Targeting CD44 as a novel therapeutic approach for treating pancreatic cancer recurrence. Oncoscience . 2015;2(6):572–575. doi:10.18632/oncoscience.172 26244163
   PubMedGoogle Scholar
• Sergeant G , Roskams T , van Pelt J , Houtmeyers F , Aerts R , Topal B . Perioperative cancer cell dissemination detected with a real-time RT-PCR assay for EpCAM is not associated with worse prognosis in pancreatic ductal adenocarcinoma. BMC Cancer . 2011;11:47. doi:10.1186/1471-2407-11-47 21281486
   PubMed Web of Science ®Google Scholar